insights_auto
Pse është rritur 0QF 7,27%?
Zhytu më thellëchevron_right
0QF:ETR
Moderna Inc
187,76 €
arrow_upward
+7,27%(+12,72) 1D
9 tet, 5:35:58 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 0QF...
Hap
175,40 €
I lartë
193,58 €
I ulët
174,18 €
Kapitalizimi i tregut
87,59 mld
Vëllimi mesatar
28,88 mijë
Vëllimi
40,72 mijë
Maksimumi 52-javor
193,58 €
Minimumi 52-javor
19,37 €
Numri i punonjësve
5 mijë
Hap
175,40 €
I lartë
193,58 €
I ulët
174,18 €
Kapitalizimi i tregut
87,59 mld
Vëllimi mesatar
28,88 mijë
Vëllimi
40,72 mijë
Maksimumi 52-javor
193,58 €
Minimumi 52-javor
19,37 €
Numri i punonjësve
5 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
TipRanks
·
13 minuta më parë
Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors
Timothy Sykes
·
28 minuta më parë
MRNA Stock Jumps As Nasdaq-100 Inclusion And Cancer Pipeline Heat Up
TradingView
·
40 minuta më parë
Moderna, Inc. Stock 12‑Month Price Target Raised to $118.42, Implies 40% Downside
Yahoo Finance
·
45 minuta më parë
Moderna stock jumps on planned national cancer vaccine effort
Profili
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Rreth Moderna Inc
Drejtori ekzekutivStephane Bancel
Punonjësit4,7 mijë
Themeluar mësht 2010
Selia-
Sektori-
Uebsajtimodernatx.com